Paper3960070
Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions.
Piomelli S and 4 others. N Engl J Med, 1986. Cited by 71 papers, by iCite.
Cite this record
ConductScience Library. Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions. Papers, record 3960070. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3960070
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Transfusion | Major topic |
| Erythropoiesis | Major topic |
| Porphyrias | Major topic |
| Child | |
| Hematocrit | |
| Humans | |
| Iron | |
| Male | |
| Photosensitivity Disorders | |
| Porphyrins |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AM 18549 | NIADDK NIH HHS | United States | R01AM018549 | PubMed and NIH | NIH RePORTER |
| AM 26793 | NIADDK NIH HHS | United States | R01AM026793 | PubMed and NIH | NIH RePORTER |
| ES 02343 | NIEHS NIH HHS | United States | R01ES002343 | PubMed and NIH | NIH RePORTER |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42213346 | Understanding the Clinical Spectrum of the Cutaneous and Acute Hepatic Porphyrias. | Am J Clin Dermatol | 2026 | https://conductscience.org/library/papers/42213346 | PubMed |
| 36217751 | Very Early Diagnosis and Management of Congenital Erythropoietic Porphyria. | Clin Pediatr (Phila) | 2023 | https://conductscience.org/library/papers/36217751 | PubMed |
| 36144223 | Iron Metabolism in the Disorders of Heme Biosynthesis. | Metabolites | 2022 | https://conductscience.org/library/papers/36144223 | PubMed |
| 34679493 | Porphyrias in the Age of Targeted Therapies. | Diagnostics (Basel) | 2021 | https://conductscience.org/library/papers/34679493 | PubMed |
| 31919078 | Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria. | Haematologica | 2021 | https://conductscience.org/library/papers/31919078 | PubMed |
| 30783081 | Dental-craniofacial manifestation and treatment of rare diseases. | Int J Oral Sci | 2019 | https://conductscience.org/library/papers/30783081 | PubMed |
| 30737139 | Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies. | Mol Genet Metab | 2019 | https://conductscience.org/library/papers/30737139 | PubMed |
| 30685241 | Congenital erythropoietic porphyria: Recent advances. | Mol Genet Metab | 2019 | https://conductscience.org/library/papers/30685241 | PubMed |
| 28899405 | Neonatal hemolytic anemia does not always indicate thalassemia: a case report. | BMC Res Notes | 2017 | https://conductscience.org/library/papers/28899405 | PubMed |
| 26631056 | [Congenital erythropoietic porphyria : An update]. | Hautarzt | 2016 | https://conductscience.org/library/papers/26631056 | PubMed |
| 25972160 | Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria. | Blood | 2015 | https://conductscience.org/library/papers/25972160 | PubMed |
| 22791288 | The porphyrias: advances in diagnosis and treatment. | Blood | 2012 | https://conductscience.org/library/papers/22791288 | PubMed |
| 19965637 | Congenital erythropoietic porphyria: a novel uroporphyrinogen III synthase branchpoint mutation reveals underlying wild-type alternatively spliced transcripts. | Blood | 2010 | https://conductscience.org/library/papers/19965637 | PubMed |
| 16532394 | Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions. | Am J Hum Genet | 2006 | https://conductscience.org/library/papers/16532394 | PubMed |
| 11244446 | Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature. | Bone Marrow Transplant | 2001 | https://conductscience.org/library/papers/11244446 | PubMed |
| 9211198 | Erythropoietic protoporphyria. | J Inherit Metab Dis | 1997 | https://conductscience.org/library/papers/9211198 | PubMed |
| 3340434 | Radiological features in congenital erythropoietic porphyria (Gunther's disease). Report of 3 cases. | Pediatr Radiol | 1988 | https://conductscience.org/library/papers/3340434 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3960070
GET https://conductscience.org/api/papers/v1/3960070/authors